Business
GPX: Record Q4 sales, positive EBITDA, and strategic expansion despite lower annual revenue
GPX: Record Q4 sales, positive EBITDA, and strategic expansion despite lower annual revenue
About this update from Gasporox Ab
Record Q4 sales and strong H2 recovery led to positive EBITDA, though annual revenue declined. Strategic investments and a 13 MSEK capital raise supported new product launches and market expansion, with pharma as the main revenue driver and growing recurring service income.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.